Pilchardus Study

Latest
News

Directory Links News Contact


Anna Novials, MD, PhD
Director, IDIBAPS Diabetes and Obesity Research Laboratory (Barcelona, Spain)

Adjunct Scientific Director, CIBERDEM, Spain

Group Leader, IDIBAPS Diabetes and Obesity Laboratory
Keywords Publications
Diabetes mellitus. Islet degeneration and damage. Pancreatic beta-cell dysfunction. Exercise and lifestyle factors in DMT2. Islet amyloid polypeptide / Amylin. Amyloid deposits. Beta secretase (BACE2). Transcription factors. Endothelium. http://www.ncbi.nlm.nih.gov/pubmed?term=novials%20a
Research Summary
The current research goals of Dr. Anna Novials’ group are focused on the mechanisms of pancreatic islet dysfunction in type 2 diabetes mellitus, the signaling and transcription networks in the pancreatic beta cell, and the metabolic and molecular responses of diabetic patients to exercise and nutrition programs.
Background
Dr. Anna Novials received her PhD from the University of Barcelona, centering her studies on the effect of glucotoxicity on pancreatic function in diabetic patients. A postdoctoral stay at the University of Cambridge and collaborations with the University of Oxford enriched her scientific and technical knowledge of key aspects of molecular biology, turning her research objectives toward the molecular mechanisms that affect pancreatic islet functioning in diabetes, which she would then develop at the Hospital Clínic de Barcelona – August Pi i Sunyer Biomedical Research Institute (IDIBAPS).

From 1998 to 2008, Dr. Novials conducted her research at the Sardà Farriol Foundation in Barcelona, first as Head of the Diabetology Unit and later as Executive Director. Finally, in 2008, she rejoined the IDIBAPS as Director of the Diabetes and Obesity Research Laboratory, where she has trained researchers that have gone on to publish their results in high-impact international journals. Since 2010, she has also served as Adjunct Scientific Director of the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM). Finally, Dr. Novials occupies important appointments, currently as Vice President of the Spanish Diabetes Society and Council Member of the European Association for the Study of Diabetes (EASD).

Throughout her career, Dr. Novials has promoted and led important initiatives bridging basic and clinical research in the field of diabetes, without ever abandoning her duty to patients as a practicing healthcare professional.